Tens Of Thousands To Benefit From English Funding Nod For siRNA Cholesterol Drug Leqvio

The NHS Will Commission The Drug’s Rollout ‘With Immediate Effect’

A landmark population-level agreement between Novartis and the National Health Service for the gene silencing therapy Leqvio is now being implemented following the thumbs up from health technology assessment body NICE.

NICE says Leqvio is cost effective • Source: Alamy

More from United Kingdom

More from Europe